Michael Timaner
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Oncology 15
- Cancer Cells and Metastasis 9
- Cytokine Signaling Pathways and Interactions 2
- Immunology 11
- Immune cells in cancer 6
- Phagocytosis and Immune Regulation 2
- Co-authors
- Yuval Shaked (20 shared papers)Kelvin K. Tsai (1 shared paper)Ziv Raviv (13 shared papers)Ofrat Beyar‐Katz (4 shared papers)Madeleine Benguigui (5 shared papers)Dov Hershkovitz (3 shared papers)Dror Alishekevitz (5 shared papers)Peleg Hasson (2 shared papers)
- Journals
- Oncotarget (4 papers)Cell Reports (2 papers)Oncogene (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Research (2 papers)
- Partner nations
- IsraelUnited StatesTaiwan
In The Last Decade
Michael Timaner
19 papers receiving 755 citations
Peers
Comparison fields: 5 of 78
- Oncology 359
- Cancer Research 170
- Immunology 232
- Genetics 106
- Molecular Biology 301
Countries citing papers authored by Michael Timaner
This map shows the geographic impact of Michael Timaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Timaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Timaner more than expected).
Fields of papers citing papers by Michael Timaner
This network shows the impact of papers produced by Michael Timaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Timaner. The network helps show where Michael Timaner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Timaner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 131 | |
| 2 | 2016 | 91 | |
| 3 | 2018 | 83 | |
| 4 | 2017 | 81 | |
| 5 | 2019 | 77 | |
| 6 | 2021 | 55 | |
| 7 | 2019 | 42 | |
| 8 | 2019 | 30 | |
| 9 | 2015 | 30 | |
| 10 | 2017 | 27 | |
| 11 | 2021 | 23 | |
| 12 | 2016 | 23 | |
| 13 | 2016 | 18 | |
| 14 | 2020 | 14 | |
| 15 | 2015 | 8 | |
| 16 | 2017 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2019 | 0 |
About Michael Timaner
Michael Timaner is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Genetics, having authored 20 papers that have together received 758 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Immune cells in cancer (6 papers), Histone Deacetylase Inhibitors Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Mesenchymal stem cell research (2 papers), Phagocytosis and Immune Regulation (2 papers), Cancer Research and Treatments (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Oncology (359 citations), Cancer Research (170 citations), Immunology (232 citations), Genetics (106 citations) and Molecular Biology (301 citations). Michael Timaner has collaborated with scholars based in Israel, United States and Taiwan. Frequent co-authors include Yuval Shaked, Kelvin K. Tsai, Ziv Raviv, Ofrat Beyar‐Katz, Madeleine Benguigui, Dov Hershkovitz, Dror Alishekevitz, Peleg Hasson, Orit Kaidar‐Person and Tomer Bronshtein. Their work appears in journals such as Oncotarget, Cell Reports, Oncogene, Journal for ImmunoTherapy of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.